<SEC-DOCUMENT>0001193125-22-308372.txt : 20221219
<SEC-HEADER>0001193125-22-308372.hdr.sgml : 20221219
<ACCEPTANCE-DATETIME>20221219164206
ACCESSION NUMBER:		0001193125-22-308372
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20221219
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221219
DATE AS OF CHANGE:		20221219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HCA Healthcare, Inc.
		CENTRAL INDEX KEY:			0000860730
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				273865930
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11239
		FILM NUMBER:		221471633

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARK PLZ
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		6153449551

	MAIL ADDRESS:	
		STREET 1:		ONE PARK PLAZA
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA Holdings, Inc.
		DATE OF NAME CHANGE:	20101126

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA INC/TN
		DATE OF NAME CHANGE:	20010627

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA THE HEALTHCARE CO
		DATE OF NAME CHANGE:	20010419
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d385362d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hca="http://hcahealthcare.com/20221219" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-12-19_to_2022-12-19">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-12-19_to_2022-12-19">0000860730</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2022-12-19_to_2022-12-19" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2022-12-19_to_2022-12-19">--12-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="hca-20221219.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-12-19_to_2022-12-19"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000860730</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-19</xbrli:startDate> <xbrli:endDate>2022-12-19</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-12-19_to_2022-12-19">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-12-19_to_2022-12-19" format="ixt:datemonthdayyearen">December&#160;19, 2022</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2022-12-19_to_2022-12-19">HCA HEALTHCARE, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-12-19_to_2022-12-19" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-12-19_to_2022-12-19">001-11239</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-12-19_to_2022-12-19">27-3865930</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:49%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:49%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-12-19_to_2022-12-19">One Park Plaza</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-12-19_to_2022-12-19">Nashville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-12-19_to_2022-12-19" format="ixt-sec:stateprovnameen">Tennessee</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-12-19_to_2022-12-19">37203</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-12-19_to_2022-12-19">(615)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-12-19_to_2022-12-19">344-9551</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, Including Area Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-12-19_to_2022-12-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-12-19_to_2022-12-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-12-19_to_2022-12-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-12-19_to_2022-12-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each Class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-12-19_to_2022-12-19">Common Stock, $.01 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-12-19_to_2022-12-19">HCA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-12-19_to_2022-12-19" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-12-19_to_2022-12-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&#160;19, 2022, the Board of Directors (the &#8220;Board&#8221;) of HCA Healthcare, Inc. (the &#8220;Company&#8221;), based on the recommendation of the Nominating and Corporate Governance Committee of the Board, adopted an amendment and restatement of the Company&#8217;s Second Amended and Restated Bylaws (as so amended, the &#8220;Third Amended Bylaws&#8221;), which became effective immediately upon adoption by the Board. The amendments (a)&#160;revise&#160;Article II, Section&#160;11 with respect to the notification and other requirements related to nominations of directors and solicitations of proxies, including requiring compliance with Rule <span style="white-space:nowrap">14a-19</span> under the Securities Exchange Act of 1934, as amended, and (b)&#160;incorporate technical, ministerial, clarifying and conforming changes related to recent amendments in the Delaware General Corporation Law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Third Amended Bylaws does not purport to be complete and is qualified in its entirety by reference to the Third Amended Bylaws, which are attached to this Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;as</span> Exhibit 3.1 and incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#160;Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d385362dex31.htm">Third Amended and Restated Bylaws of HCA Healthcare, Inc., effective December&#160;19, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:47%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:46%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: December&#160;19, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">HCA HEALTHCARE, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John M. Franck II</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John M. Franck II</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Vice President &#8211; Legal and Corporate Secretary</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d385362dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THIRD </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND
RESTATED BYLAWS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HCA HEALTHCARE, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A
Delaware Corporation </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFICES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION
1.</B><B> </B><B>REGISTERED OFFICE.</B> The registered office of HCA Healthcare, Inc. (the&nbsp;&#147;Corporation&#148;) in the State of Delaware shall be located at Corporation Trust Center, 1209&nbsp;Orange Street, in the city of Wilmington,
County of New Castle, 19801. The name of the Corporation&#146;s registered agent at such address shall be The Corporation Trust Company. The registered office and/or registered agent of the Corporation may be changed from time to time by action of
the Board of Directors of the Corporation (the &#147;Board of Directors&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.</B><B> </B><B>OTHER OFFICES.</B> The
Corporation may also have offices at such other places, both within and without the State of Delaware, as the Board of Directors may from time to time determine or the business of the Corporation may require. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEETINGS OF
STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 1.</B><B> </B><B>PLACE OF MEETINGS.</B> The Board of Directors may designate any place, either within or
without the State of Delaware, as the place of meeting for any annual meeting or for any special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.</B><B>
</B><B>ANNUAL MEETING; ELECTION OF DIRECTORS.</B> The annual meeting of stockholders shall be held at such date, time and place, if any, as shall be designated by the Board of Directors and stated in a notice of meeting or in a duly executed waiver
thereof. At such annual meeting, the stockholders shall elect the Board of Directors and transact such other business as may properly be brought before the meeting. In uncontested director elections each director is elected by the vote of the
majority of the votes cast; provided, however, that if the number of nominees proposed to be elected at that annual meeting of stockholders exceeds the number of directors proposed to be elected at that annual meeting of stockholders, then the
persons receiving the greatest number of votes, up to the number of directors proposed to be elected at that annual meeting of stockholders, shall be elected. An uncontested director election means an election in which the number of nominees
proposed to be elected at that annual meeting of stockholders is equal to the number of directors proposed to be elected at that annual meeting of stockholders. A majority of the votes cast means that the number of shares voted &#147;for&#148; a
director&#146;s election exceeds the number of shares voted &#147;against&#148; that director. Shares voted shall not include a share otherwise present at the meeting but which abstains from voting on a director, or gives no authority or direction.
An incumbent nominee not receiving a majority of the votes cast shall tender his or her resignation to the secretary of the Corporation for consideration by the Board of Directors, which resignation shall be contingent upon the acceptance thereof by
the Board of Directors. The Nominating and Corporate Governance Committee of the Board of Directors shall recommend to the Board of Directors the action to be taken with respect to the resignation. The Board of Directors will publicly disclose its
decision with respect to the resignation and the rationale behind its decision within ninety (90)&nbsp;days of the certification of the election results. The Nominating and Corporate Governance Committee in making its recommendation to the Board of
Directors and the Board of Directors in making its decision with respect to the resignation may each consider any factors or other information that they consider appropriate and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
relevant. The director who tenders his or her resignation will not participate in the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors or the decision
of the Board of Directors with respect to his or her resignation. An incumbent nominee not receiving a majority of the votes cast in an uncontested election shall continue to serve until (i)&nbsp;the director&#146;s successor is elected and
qualifies or (ii)&nbsp;the Board of Directors accepts the director&#146;s resignation. If a director&#146;s resignation is accepted by the Board of Directors pursuant to this <U>Section</U><U></U><U>&nbsp;2</U>, or if a nominee for director is not
elected and the nominee is not an incumbent director, then the Board of Directors may fill the resulting vacancy pursuant to the provisions of <U>Section</U><U></U><U>&nbsp;11</U> of <U>Article III</U> of these Bylaws or may decrease the size of the
Board of Directors pursuant to the Corporation&#146;s certificate of incorporation as then in effect (the &#147;Certificate of Incorporation&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.</B><B> </B><B>SPECIAL MEETINGS.</B> A. Special meetings of the stockholders may be called at any time by the Board of Directors
pursuant to a resolution adopted by the affirmative vote of the majority of the total number of directors then in office, by the chairman of the Board of Directors, or by the chief executive officer, and, subject to the requirements of
this<U>&nbsp;Section</U><U></U><U>&nbsp;3</U>&nbsp;and such other sections of these Bylaws as are applicable, a special meeting of the stockholders shall be called by the secretary of the Corporation upon written request to the secretary of the
Corporation (each such request, a &#147;Special Meeting Request&#148; and such meeting a &#147;Stockholder Requested Special Meeting&#148;) of the holders of record of at least fifteen percent (15%) of the voting power of all outstanding shares of
common stock of the Corporation (the &#147;Common Stock&#148;) entitled to vote at such meeting, which shares are determined to be &#147;owned&#148; (as defined below) (the &#147;Requisite Percentage&#148;), who have held such shares continuously
for at least one year (such period, <FONT STYLE="white-space:nowrap">the&nbsp;&#147;One-Year&nbsp;Period&#148;)</FONT> as of both (1)&nbsp;the date (the &#147;Request Date&#148;) such Special Meeting Request is delivered to or mailed to and received
by the secretary of the Corporation in accordance with this<U>&nbsp;Section</U><U></U><U>&nbsp;3</U>&nbsp;and (2)&nbsp;the record date for determining the stockholders entitled to vote at the Stockholder Requested Special Meeting and must continue
to own the Requisite Percentage through such Stockholder Requested Special Meeting date; and who have complied in full with the requirements set forth in these Bylaws. A special meeting of stockholders, including any Stockholder Requested Special
Meeting, may be held at such date, time and place, if any, within or without the State of Delaware as may be designated by the Board of Directors; provided, however, that the date of any Stockholder Requested Special Meeting shall be no fewer than
thirty (30)&nbsp;and no more than ninety (90)&nbsp;days from the date a Special Meeting Request(s) satisfying the requirements set forth in these Bylaws and representing the Requisite Percentage is received by the secretary of the Corporation (or,
in the case of any litigation related to the validity of the Special Meeting Request(s), 90 days after the resolution of such litigation); provided, further, that the Board of Directors shall have the discretion to cancel any Stockholder Requested
Special Meeting that has been called but not yet held for any of the reasons set forth in<U>&nbsp;Section</U><U></U><U>&nbsp;3(D)</U>&nbsp;below. Except in accordance with this<U>&nbsp;Section</U>&nbsp;3, stockholders shall not be permitted to
propose business to be brought before a special meeting of the stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of determining the Requisite Percentage, a stockholder shall be
deemed to &#147;own&#148; only those shares of Common Stock as to which the stockholder(s) of record making the Special Meeting Request or beneficial owner(s), if any, on whose behalf the Special Meeting Request is being made (each such record owner
and beneficial owner, a &#147;Requesting Stockholder&#148;) possesses both (a)&nbsp;the full voting and investment rights pertaining to the shares and (b)&nbsp;the full economic interest in (including the opportunity for profit from and risk of loss
on) such shares; provided, that the number of shares calculated in accordance with clauses (a)&nbsp;and (b)&nbsp;shall not include any shares (1)&nbsp;sold by such stockholder or any of its Affiliates in any transaction that has not been settled or
closed, (2)&nbsp;borrowed by such stockholder or any of its Affiliates for any purposes or purchased by such stockholder or any of its Affiliates pursuant to an agreement to resell or (3)&nbsp;subject to any option, warrant, forward contract, swap,
contract of sale, other derivative or similar agreement entered into by such stockholder or any of its Affiliates, whether any such instrument or agreement is to be settled with shares of Common Stock of the Corporation or with cash based on the
notional amount or value of shares of outstanding Common Stock of the Corporation subject thereto, in any such case which instrument </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or agreement has, or is intended to have, the purpose or effect of (A)&nbsp;reducing in any manner, to any extent or at any time in the future, such stockholder&#146;s or its Affiliates&#146;
full right to vote or direct the voting of any such shares, and/or (B)&nbsp;hedging, offsetting or altering to any degree any gain or loss realized or realizable arising from maintaining the full economic ownership of such shares by such stockholder
or Affiliate. For purposes of this<U>&nbsp;Section</U><U></U><U>&nbsp;3</U>, a stockholder shall &#147;own&#148; shares held in the name of its bank, broker or other nominee or intermediary so long as the stockholder retains the right to instruct
how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares through the special meeting date. A stockholder&#146;s ownership of shares shall be deemed to continue during any period in
which the stockholder has delegated any voting power by means of a proxy, power of attorney or other instrument or arrangement which is revocable at any time by the stockholder. A stockholder&#146;s ownership of shares shall be deemed to continue
during any period in which the stockholder has loaned such shares, provided that the person has the power to recall such loaned shares on no more than five (5)&nbsp;business days&#146; notice and (x)&nbsp;will promptly recall such loaned shares upon
having received notice of the Stockholder Requested Special Meeting and (y)&nbsp;will continue to hold such recalled shares through the date of the Stockholder Requested Special Meeting. The terms &#147;owned,&#148; &#147;owning&#148; and other
variations of the word &#147;own&#148; shall have correlative meanings. Whether outstanding shares of Common Stock of the Corporation are &#147;owned&#148; for these purposes shall be determined by the Board of Directors or any committee thereof,
which determination shall be conclusive and binding on the Corporation and its stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. To be in proper form and valid, a Special
Meeting Request must be signed by the holders of the Requisite Percentage (or their duly authorized agents), be delivered to or mailed to and received by&nbsp;the secretary of the Corporation at the Corporation&#146;s principal executive offices by
registered mail, return receipt requested or by nationally recognized private overnight courier service and shall (A)&nbsp;set forth a statement of the specific purpose or purposes of the meeting and the matters proposed to be acted on at such
special meeting (including the text of any resolutions proposed for consideration and, if such business includes a proposal to amend the Bylaws, the language of the proposed amendment), (B)&nbsp;bear the date of signature of each stockholder (or
duly authorized agent) signing the request, (C)&nbsp;include (w)&nbsp;the name and address, as they appear in the Corporation&#146;s books, of each stockholder signing such request (or on whose behalf the request is signed), (x)&nbsp;the number of
shares of Common Stock &#147;owned&#148; by such stockholder, (y)&nbsp;one or more written statements from the record holder of the shares (and from each intermediary through which the shares are or have been held during <FONT
STYLE="white-space:nowrap">the&nbsp;One-Year&nbsp;Period)</FONT> verifying that, as of a date within seven (7)&nbsp;calendar days prior to the Request Date, the Requesting Stockholder owns, and has owned continuously for <FONT
STYLE="white-space:nowrap">the&nbsp;One-Year&nbsp;Period,</FONT> the Requisite Percentage, and the Requesting Stockholder&#146;s agreement to provide, within five (5)&nbsp;business days after the record date for the Stockholder Requested Special
Meeting, written statements from the record holder and intermediaries verifying the Requesting Stockholder&#146;s continuous ownership of the Requisite Percentage through the record date; and (z)&nbsp;a certification from the stockholder submitting
the request that the stockholders signing the request in the aggregate satisfy the Requisite Percentage, (D)&nbsp;describe any material interest of each such stockholder in the specific purpose or purposes of the meeting, (E)&nbsp;contain any other
information that would be required to be provided by a stockholder seeking to nominate directors or bring an item of business before an annual meeting of stockholders pursuant to<U>&nbsp;Section</U><U></U><U>&nbsp;11</U>&nbsp;of<U>&nbsp;Article
II</U>&nbsp;of these Bylaws, (F)&nbsp;include an acknowledgment by each stockholder and any duly authorized agent that any reduction in shares of Common Stock &#147;owned&#148; by such stockholder as of the date of delivery of the Special Meeting
Request and prior to the record date for the proposed Stockholder Requested Special Meeting shall constitute a revocation of such request to the extent of such reduction, (G)&nbsp;include an agreement by each stockholder and any duly authorized
agent to continue to satisfy the Requisite Percentage through the date of the Stockholder Requested Special Meeting and to notify the Corporation promptly, in the event of any decrease in shares of Common Stock &#147;owned&#148; by such stockholder
following the delivery of the Special Meeting Request, and (H)&nbsp;include an agreement by each stockholder and any duly authorized agent to update the information provided to the Corporation to ensure that it is true and correct as of the record
date for notice of the Stockholder Requested Special Meeting, and as of fifteen (15)&nbsp;days prior to the Stockholder Requested Special Meeting or any adjournment or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
postponement thereof, and such update shall be delivered to the secretary of the Corporation at the Corporation&#146;s principal executive offices by registered mail, return receipt requested or
by nationally recognized private overnight courier service not later than five (5)&nbsp;days after the record date of the Stockholder Requested Special Meeting (in the case of the update required to be made as of the record date), and not later than
ten (10)&nbsp;days prior to the date of the Stockholder Requested Special Meeting or, if practical, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the Stockholder Requested
Special Meeting has been adjourned or postponed) (in the case of the update required to be made as of fifteen (15)&nbsp;days prior to the Stockholder Requested Special Meeting or any adjournment or postponement thereof). In addition, the stockholder
and any duly authorized agent shall promptly provide any other information reasonably requested by the Corporation. For the avoidance of doubt, in the event that the Requesting Stockholder consists of a group of stockholders, the requirements and
obligations applicable to an individual Requesting Stockholder that are set forth in these Bylaws, including <FONT STYLE="white-space:nowrap">the&nbsp;One-Year&nbsp;Period,</FONT> shall apply to each member of such group individually; provided,
however, that the Requisite Percentage shall apply to the continuous ownership of the eligible group in the aggregate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. In determining
whether a special meeting of stockholders has been requested by the record holders of shares representing in the aggregate at least the Requisite Percentage who have held such shares continuously for
<FONT STYLE="white-space:nowrap">the&nbsp;One-Year&nbsp;Period,</FONT> multiple Special Meeting Requests delivered to the secretary of the Corporation will be considered together only if (i)&nbsp;each Special Meeting Request identifies substantially
the same purpose or purposes of the special meeting and substantially the same matters proposed to be acted on at the special meeting, in each case as determined by the Board of Directors (which, if such purpose is the nominating of a person or
persons for election to the Board of Directors, will mean that the exact same person or persons are nominated in each relevant Special Meeting Request), and (ii)&nbsp;such Special Meeting Requests have been dated and delivered to the secretary of
the Corporation within sixty (60)&nbsp;days of the earliest dated Special Meeting Request. A stockholder may revoke a Special Meeting Request at any time by written revocation delivered to the secretary of the Corporation. If, following such
revocation, there are unrevoked requests from stockholders representing in the aggregate less than the Requisite Percentage, the Board of Directors, in its discretion, may cancel the special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. At any Stockholder Requested Special Meeting, the business transacted shall be limited to the purpose(s) stated in the Special Meeting
Request; provided, however, that the Board of Directors shall have the authority in its discretion to submit additional matters to the stockholders and to cause other business to be transacted. Notwithstanding the foregoing provisions of
this<U>&nbsp;Section</U><U></U><U>&nbsp;3</U>, a Stockholder Requested Special Meeting shall not be held if (i)&nbsp;the Special Meeting Request does not comply with these Bylaws, (ii)&nbsp;the business specified in the Special Meeting Request is
not a proper subject for stockholder action under applicable law, (iii)&nbsp;the Board of Directors has called or calls for an annual or special meeting of stockholders to be held within 90&nbsp;days after the secretary of the Corporation receives
the Special Meeting Request and the Board of Directors determines that the business of such meeting includes (among any other matters properly brought before the annual or special meeting) the business specified in the Special Meeting Request,
(iv)&nbsp;the Special Meeting Request is received by the secretary of the Corporation during the period commencing 90&nbsp;days prior to the anniversary date of the prior year&#146;s annual meeting of stockholders and ending on the date of the final
adjournment of the next annual meeting of stockholders, (v)&nbsp;an identical or substantially similar item (a &#147;Similar Item&#148;) was presented at any meeting of stockholders held within 90 days prior to receipt by the secretary of the
Corporation of the Special Meeting Request (and, for purposes of this clause (v), the nomination, election or removal of directors shall be deemed a &#147;Similar Item&#148; with respect to all items of business involving the nomination, election or
removal of directors, the changing of the size of the Board of Directors and the filling of vacancies and/or newly created directorships), or (vi)&nbsp;the Special Meeting Request was made in a manner that involved a violation of Regulation 14A
under the Exchange Act (as hereinafter defined), or other applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. Except to the extent previously determined by the Board of Directors in connection with a
Special Meeting Request, the chairperson of the Stockholder Requested Special Meeting shall determine at such meeting whether any proposed business or other matter to be transacted by the stockholders has not been properly brought before the special
meeting and, if he or she should so determine, the chairperson shall declare that such proposed business or other matter was not properly brought before the meeting and such business or other matter shall not be presented for stockholder action at
the meeting. In addition, notwithstanding the foregoing provisions of this<U>&nbsp;Section</U><U></U><U>&nbsp;3</U>, unless otherwise required by law, if the Requesting Stockholder(s) (or a qualified representative of the stockholder) does not
appear at the Stockholder Requested Special Meeting to present a nomination or other proposed business, such nomination shall be disregarded and such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may
have been received by the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.</B><B> </B><B>NOTICE OF MEETINGS.</B> Whenever stockholders are required or
permitted to take action at a meeting, notice of each annual and special meeting of stockholders stating the date, time and place, if any, of the meeting, the record date for determining the stockholders entitled to vote at the meeting (if such date
is different from the record date for stockholders entitled to notice of the meeting), and, in the case of a special meeting, the purpose or purposes for which the meeting is called, shall be given to each stockholder of record entitled to vote at
the meeting as of the record date for determining stockholders entitled to notice of the meeting not less than ten (10)&nbsp;nor more than sixty (60)&nbsp;days before the date of the meeting. Business transacted at any special meeting of
stockholders shall be limited to the purpose or purposes stated in the notice. Subject to the requirements of applicable law, notice may be provided by mail, private carrier, facsimile transmission or other form of wire, wireless or other means of
electronic transmission. Subject to the requirements of applicable law, notice provided to a stockholder&#146;s <FONT STYLE="white-space:nowrap">e-mail</FONT> address as indicated on the records of the Corporation shall be deemed proper notice for
any purpose set forth in these Bylaws. Notice by mail shall be deemed given at the time when the same shall be deposited in the United States mail, postage prepaid. Notice of any meeting shall not be required to be given to any person who attends
such meeting, except when such person attends the meeting in person or by proxy for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened, or who,
either before or after the meeting, shall submit a signed written waiver of notice, in person or by proxy. Neither the business to be transacted at, nor the purpose of, an annual or special meeting of stockholders need be specified in any waiver of
notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.</B><B> </B><B>LIST OF STOCKHOLDERS.</B> The officer having charge of the stock ledger of the Corporation shall
prepare and make, at least ten (10)&nbsp;days before each meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting (provided, however, if the record date for determining the stockholders entitled to vote is less
than ten (10)&nbsp;days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth day before the meeting date), arranged in alphabetical order, showing the address of and the number of shares registered
in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of at least ten (10)&nbsp;days prior to the meeting: (a)&nbsp;on a reasonably accessible electronic
network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (b)&nbsp;during ordinary business hours, at the principal place of business of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.</B><B> </B><B>QUORUM; ADJOURNMENTS.</B> The holders of a majority of the voting power of the issued and outstanding stock of the
Corporation entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of stockholders, except as otherwise provided by statute or by the Certificate of
Incorporation. If, however, such quorum shall not be present or represented by proxy at any meeting of stockholders, the chairman of the meeting or the stockholders entitled to vote thereon, present in person or represented by proxy, shall have the
power to adjourn the meeting from time to time until a quorum shall be present or represented by proxy. When a meeting is adjourned to another time or place, if any, notice need not be given of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
adjourned meeting if the time and place, if any, of such adjourned meeting, and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in
person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken or are provided in any other manner permitted by the General Corporation Law of the State of Delaware. At such adjourned meeting at which a
quorum shall be present or represented by proxy, any business may be transacted which might have been transacted at the meeting as originally called. If the adjournment is for more than thirty (30)&nbsp;days, a notice of the adjourned meeting shall
be given to each stockholder of record entitled to vote at the meeting. If after adjournment a new record date for the determination of stockholders entitled to vote is set, the Board of Directors shall fix as the record date for determining
stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting, and shall give a notice of the adjourned meeting to each stockholder of
record as of the record date fixed for notice of the adjourned meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.</B><B> </B><B>ORGANIZATION; CONDUCT OF MEETING.</B>
At each meeting of stockholders, the chairman of the board, if one shall have been elected, or, in his absence or if one shall not have been elected, the chief executive officer shall act as chairman of the meeting. The secretary or, in his absence
or inability to act, the person whom the chairman of the meeting shall appoint secretary of the meeting shall act as secretary of the meeting and keep the minutes thereof. The date and time of the opening and the closing of the polls for each matter
upon which the stockholders will vote at a meeting shall be announced at the meeting by the chairman of the meeting. The Board of Directors may adopt by resolution such rules and regulations for the conduct of the meeting of stockholders as it shall
deem appropriate. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the chairman of the meeting shall have the right and authority to convene and (for any or no reason) to recess and/or adjourn
the meeting, to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board
of Directors or prescribed by the chairman of the meeting, may include, without limitation, the following: (i)&nbsp;rules and procedures for maintaining order at the meeting and the safety of those present; (ii)&nbsp;limitations on attendance at or
participation in the meeting to stockholders entitled to vote at the meeting, their duly authorized and constituted proxies or such other persons as the chairman of the meeting shall determine; (iii)&nbsp;restrictions on entry to the meeting after
the time fixed for the commencement thereof; and (iv)&nbsp;limitations on the time allotted to questions or comments by participants. The chairman of the meeting of stockholders, in addition to making any other determinations that may be appropriate
to the conduct of the meeting, shall, if the facts warrant, determine and declare to the meeting that a nomination or matter or business was not properly brought before the meeting and if such chairman should determine, such chairman shall so
declare to the meeting and any such nomination or matter or business not properly brought before the meeting shall not be transacted or considered. Unless and to the extent determined by the Board of Directors or the chairman of the meeting,
meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 8.</B><B>
</B><B>ORDER OF BUSINESS.</B> The order of business at all meetings of the stockholders shall be as determined by the chairman of the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 9.</B><B> </B><B>VOTING.</B> Except as otherwise provided by the Certificate of Incorporation, the General Corporation Law of the
State of Delaware or the certificate of designation relating to any outstanding class or series of preferred stock, each stockholder of the Corporation shall be entitled at each meeting of stockholders to one vote for each share of capital stock of
the Corporation standing in his name on the record of stockholders of the Corporation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. on the date fixed pursuant to the provisions of
<U>Section</U><U></U><U>&nbsp;13</U> of this <U>Article II</U> as the record date for the determination of the stockholders who shall be entitled to vote at such meeting; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. if no such record date shall have been so fixed, the record date for determining
stockholders entitled to notice of and to vote at a meeting of stockholders shall be the close of business on the day next preceding the day on which notice thereof shall be given, or, if notice is waived, at the close of business on the date next
preceding the day on which the meeting is held. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each stockholder entitled to vote at any meeting of stockholders may authorize another
person or persons to act for him by a proxy which is in writing or transmitted as permitted by law, including, without limitation, electronically, via telegram, internet, interactive voice response system, or other means of electronic transmission
executed or authorized by such stockholder or his <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> but no proxy shall be voted after three (3)&nbsp;years from its date, unless the proxy provides for a
longer period. Any such proxy shall be delivered to the secretary of the meeting at or prior to the time designated in the order of business for so delivering such proxies. Any proxy transmitted electronically shall set forth information from which
it can be determined by the secretary of the meeting that such electronic transmission was authorized by the stockholder. When a quorum is present at any meeting, the vote of the holders of a majority of the voting power of the issued and
outstanding stock of the Corporation entitled to vote thereon, present in person or represented by proxy, shall decide any question brought before such meeting, unless the question is one upon which by express provision of the General Corporation
Law of the State of Delaware, the rules or regulations of any stock exchange applicable to the Corporation or pursuant to any law or regulation applicable to the Corporation or its securities or of the Certificate of Incorporation or of these
Bylaws, a different vote is required, in which case such express provision shall govern and control the decision of such question. Unless required by statute, or determined by the chairman of the meeting to be advisable, the vote on any question
need not be by ballot. On a vote by ballot, each ballot shall be signed by the stockholder voting, or by his proxy, if there be such proxy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 10.</B><B> </B><B>INSPECTORS.</B> The Board of Directors may, and shall if required by law, in advance of any meeting of
stockholders, appoint one or more inspectors to act at such meeting or any adjournment thereof. If any of the inspectors so appointed shall fail to appear or act, the chairman of the meeting shall, or if inspectors shall not have been appointed, the
chairman of the meeting may, appoint one or more inspectors. Each inspector, before entering upon the discharge of his duties, shall take and sign an oath to faithfully execute the duties of inspector at such meeting with strict impartiality and
according to the best of his ability. The inspectors shall determine the number of shares of capital stock of the Corporation outstanding and the voting power of each, the number of shares represented at the meeting, the existence of a quorum, the
validity and effect of proxies, and shall receive votes, ballots or consents, hear and determine all challenges and questions arising in connection with the right to vote, count and tabulate all votes, ballots or consents, determine the results, and
do such acts as are proper to conduct the election or vote with fairness to all stockholders. On request of the chairman of the meeting, the inspectors shall make a report in writing of any challenge, request or matter determined by them and shall
execute a certificate of any fact found by them. In determining the validity and counting of proxies and ballots cast at any meeting of stockholders of the Corporation, the inspectors may consider such information as is permitted by applicable law.
No director or candidate for the office of director shall act as an inspector of an election of directors. Inspectors need not be stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 11. PROPOSALS AND NOMINATIONS FOR MEETINGS OF STOCKHOLDERS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. At an annual meeting of stockholders, only such nominations of persons for election to the Board of Directors and other business shall be
conducted as shall have been properly brought before the meeting. To be properly brought before an annual meeting, nominations and other business must be: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">brought before the meeting by the Corporation and specified in the notice of meeting (or any supplement
thereto) given by or at the direction of the Board of Directors or an authorized committee thereof, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">brought before the meeting by or at the direction of the Board of Directors or an authorized committee thereof,
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">otherwise properly brought before the meeting by a stockholder who: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">was a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such
nominations of persons for election to the Board of Directors or other business is proposed, only if such beneficial owner was the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for in this
<U>Section</U><U></U><U>&nbsp;11</U> and at the time of the meeting, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is entitled to vote at the meeting, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">has complied with this <U>Section</U><U></U><U>&nbsp;11</U> and, if applicable,
<U>Section</U><U></U><U>&nbsp;14</U> of this <U>Article II</U> as to such business. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for proposals properly made in accordance
with Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (as so amended and inclusive of such rules and regulations, the &#147;Exchange Act&#148;), or
pursuant to <U>Section</U><U></U><U>&nbsp;14</U> of this <U>Article II</U>, the foregoing clause (iii)&nbsp;shall be the exclusive means for a stockholder to propose business to be brought before an annual meeting of stockholders or to make any
nomination of a person or persons for election to the Board of Directors at an annual meeting of stockholders. The only matters that may be brought before a special meeting of stockholders are the matters specified in the notice of meeting given by
or at the direction of the person calling the meeting pursuant to <U>Section</U><U></U><U>&nbsp;4</U> of this <U>Article II</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. For
business to be properly brought before an annual meeting by a stockholder, or for a stockholder to make any nomination of a person or persons for election to the Board of Directors at an annual meeting or a special meeting of stockholders properly
called for the election of directors pursuant to <U>Section</U><U></U><U>&nbsp;3</U> of this <U>Article II</U>, the stockholder must provide timely written notice in proper form to the Corporation (the &#147;Stockholder Notice&#148;) and provide any
updates or supplements to such Stockholder Notice at the times and in the forms required by this <U>Section</U><U></U><U>&nbsp;11</U> (or, as applicable, <U>Section</U><U></U><U>&nbsp;14</U> of this <U>Article II</U>). This
<U>Section</U><U></U><U>&nbsp;11</U> shall constitute an &#147;advance notice provision&#148; for purposes of Rule <FONT STYLE="white-space:nowrap">14a-4(c)(1)</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. To be timely, the Stockholder Notice must be delivered to, or mailed and received at, the principal executive offices of the Corporation,
addressed to the secretary of the Corporation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of an annual meeting, no earlier than one hundred twenty (120)&nbsp;days and no later than ninety
(90)&nbsp;days prior to the first anniversary of the date of the preceding year&#146;s annual meeting; provided, however, that if (A)&nbsp;the annual meeting is advanced by more than thirty (30)&nbsp;days, or delayed by more than sixty
(60)&nbsp;days, from the first anniversary of the preceding year&#146;s annual meeting, or (B)&nbsp;no annual meeting was held during the preceding year, to be timely the Stockholder Notice must be received no earlier than one hundred twenty
(120)&nbsp;days before such annual meeting and no later than the later of ninety (90)&nbsp;days before such annual meeting or the tenth day after the day on which Public Disclosure of the date of such meeting is first made, and
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a nomination of a person or persons for election to the Board of Directors at a special meeting
of stockholders called for the purpose of electing directors, no earlier than one hundred twenty (120)&nbsp;days before such special meeting and no later than the later of ninety (90)&nbsp;days before such special meeting or the tenth day after the
day on which Public Disclosure of the date of such meeting is first made. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In no event shall an adjournment, postponement or deferral,
or Public Disclosure of an adjournment, postponement or deferral, of a meeting of stockholders commence a new time period (or extend any time period) for the giving of the Stockholder Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. To be in proper form, the Stockholder Notice must: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">set forth the name and address of the stockholder giving the Stockholder Notice (and any beneficial owner, if
different, on whose behalf such Stockholder Notice is submitted) (the stockholder giving the Stockholder Notice, or, if the Stockholder Notice is submitted on behalf of a beneficial owner, such beneficial owner, is referred to herein as the
&#147;Proponent&#148;) as they appear on the Corporation&#146;s books and the name and address of any Stockholder Associated Person(s) for which disclosure is required by clause (ii)&nbsp;below, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">set forth the following information: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the class and number of shares of capital stock of the Corporation that are owned beneficially (within the
meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) and of record by the Proponent and any Stockholder Associated Person, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date such shares were acquired, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a description in reasonable detail of any option, warrant, convertible security, stock appreciation right or
similar right directly or indirectly owned by the Proponent or any Stockholder Associated Person with an exercise or conversion privilege or a settlement payment or mechanism at a price related to shares of any class or series of stock of the
Corporation, or with a value derived in whole or in part from the price, value or volatility of shares of any class or series of stock of the Corporation, whether or not such instrument or right shall convey any voting rights in such shares, be
subject to settlement in the underlying class or series of stock of the Corporation or be subject to other transactions that hedge or mitigate the economic effect of such transactions, or any other direct or indirect opportunity to profit from any
increase or decrease in the value of shares of any class or series of stock of the Corporation (&#147;Derivative Interests&#148;), </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a description in reasonable detail of any proxy, contract, arrangement, understanding or other relationship
pursuant to which the Proponent or any Stockholder Associated Person has a right to vote any shares of any class or series of stock of the Corporation (other than a revocable proxy or consent given in response to a solicitation made pursuant to, and
in accordance with, Section&nbsp;14(a) of the Exchange Act by way of a solicitation statement filed on Schedule 14A), </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any agreement, arrangement, understanding or relationship, including any repurchase or <FONT
STYLE="white-space:nowrap">so-called</FONT> &#147;stock borrowing&#148; agreement or arrangement, engaged in directly or indirectly by the Proponent or any Stockholder Associated Person, the purpose or effect of which is to mitigate loss to, reduce
the economic risk (of ownership or otherwise) of shares of any class or series of the Corporation by, manage the risk of share price changes for, or increase or decrease the voting power of, such Proponent or Stockholder Associated Person with
respect to the shares of any class or series of stock of the Corporation, or which provides, directly or indirectly, the opportunity to profit from any decrease in the price or value of the shares of any class or series of stock of the Corporation
(&#147;Short Interests&#148;), </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any rights to dividends on the shares of any class or series of stock of the Corporation owned beneficially by
the Proponent or any Stockholder Associated Person that are separated or separable from the underlying shares of stock of the Corporation, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any performance-related fees (other than an asset-based fee) that the Proponent or any Stockholder Associated
Person is entitled to based on any increase or decrease in the value of shares of any class or series of the stock of the Corporation or any Derivative Interest or Short Interest, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any arrangements, rights or other interests described in <U>Section</U><U></U><U>&nbsp;11(D)(ii)(c)-(g)</U>
above held by members of the Proponent&#146;s or any Stockholder Associated Person&#146;s immediate family sharing the same household, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a representation (i)&nbsp;that the Proponent intends to appear in person or by proxy at the meeting to nominate
the person(s) named or propose the business specified in the Stockholder Notice and (ii)&nbsp;that the Proponent intends or is part of a group which intends to solicit proxies or votes in support of such director nominees in accordance with Rule <FONT
STYLE="white-space:nowrap">14a-19</FONT> promulgated under the Exchange Act and, if such Proponent proposes other business, whether or not the Proponent intends to deliver a proxy statement and/or form of proxy to holders of at least the percentage
of the Corporation&#146;s outstanding shares of capital stock required to approve the business proposed and/or otherwise to solicit proxies or votes from stockholders in support of the other business proposed, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a certification regarding whether or not the Proponent and Stockholder Associated Person(s) have complied with
all applicable federal, state and other legal requirements in connection with the Proponent&#146;s and/or Stockholder Associated Persons&#146; acquisition of shares of capital stock or other securities of the Corporation and/or the Proponent&#146;s
and/or Stockholder Associated Persons&#146; acts or omissions as a stockholder of the Corporation, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other information relating to the Proponent that would be required to be disclosed in a proxy statement or
other filings required to be made in connection with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in a contested election pursuant to Section&nbsp;14 of the Exchange Act and the rules and regulations
thereunder, and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other information as reasonably requested by the Corporation (the disclosures to be made pursuant to the
foregoing causes (a)&nbsp;through (k) are referred to as &#147;Disclosable Interests&#148;; provided, however, that Disclosable Interests shall not include any such disclosures with respect to the ordinary course business activities of any broker,
dealer, commercial bank, trust company or other nominee who is a Proponent solely as a result of being the stockholder directed to prepare and submit the Stockholder Notice on behalf of a beneficial owner). </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The Proponent shall update and supplement the Stockholder Notice and any other information provided to the Corporation so that such
information is true and correct as of the record date and as of the date that is ten (10)&nbsp;business days prior to the meeting or any adjournment, postponement or rescheduling thereof. The update and supplement shall clearly identify the
information that has changed since the Proponent&#146;s prior submission, it being understood that no such update may cure any deficiencies or inaccuracies with respect to any such prior submission or extend the time period for delivery of notice
pursuant to this <U>Section</U><U></U><U>&nbsp;11</U>. If a Proponent fails to provide such written update within such period, the information as to which such written update relates may be deemed not to have been provided in accordance with this
<U>Section</U><U></U><U>&nbsp;11</U>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the Stockholder Notice relates to any business that the Proponent proposes to bring before the meeting other
than a nomination of a person or persons for election to the Board of Directors, it must set forth: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a brief description of the business that the Proponent proposes to bring before the meeting, the text of the
proposal (including the text of any resolutions proposed for consideration and, if such business includes a proposal to amend the Certificate of Incorporation or Bylaws, the language of the proposed amendment) and the reasons for conducting such
business at the meeting, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any material interest in such business of the Proponent or any Stockholder Associated Person, and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a reasonably detailed description of all agreements, arrangements and understandings between the Proponent or
any Stockholder Associated Person and any other person (including their names) in connection with the proposed business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iv.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">set forth, as to each person, if any, whom the Proponent proposes to nominate for election or reelection to the
Board of Directors: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all information relating to the nominee (including, without limitation, the nominee&#146;s name, age, business
and residence address and principal occupation or employment and the class or series and number of shares of capital stock of the Corporation that are owned beneficially or of record
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
by the nominee) that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for an election of directors in a
contested election pursuant to Section&nbsp;14 of the Exchange Act and the rules and regulations thereunder (including such person&#146;s written consent to being named as a nominee in a proxy statement relating to the Corporation&#146;s annual or
special meeting of stockholders at which directors will be elected and to serving as a director if elected), </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a description of any agreements, arrangements and understandings between or among the Proponent or any
Stockholder Associated Person, on the one hand, and any other persons (including any Stockholder Associated Person), on the other hand, in connection with the nomination of such person for election as a director, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a description of all direct and indirect compensation and other material monetary agreements, arrangements, and
understandings during the past three years, and any other material relationships, between or among the Proponent or any Stockholder Associated Person, on the one hand, and each proposed nominee, and his or her respective affiliates and associates,
on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> if the Proponent making the nomination or on whose behalf the
nomination is made, if any, or any Stockholder Associated Person, were the &#147;registrant&#148; for purposes of Item 404 and the nominee were a director or executive officer of such registrant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">v.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">include a completed and signed questionnaire with respect to each nominee for election or reelection to the
Board of Directors, in the form to be provided by the secretary of the Corporation upon request, setting forth the information described in clause (E)&nbsp;below. The Corporation may require any proposed nominee to furnish such other information as
may reasonably be required by the Corporation to determine the eligibility of the proposed nominee to serve as an independent director of the Corporation or that could be material to a reasonable stockholder&#146;s understanding of the independence,
or lack thereof, of the nominee. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. For a nominee of a stockholder to be eligible to be a nominee for election or
reelection as a director of the Corporation, a person must complete and deliver (in accordance with the time periods prescribed for delivery of a Stockholder Notice under this <U>Section</U><U></U><U>&nbsp;11</U> or, in the case of a Stockholder
Nominee (as defined below), the time periods prescribed for delivery of a Proxy Access Notice under <U>Section</U><U></U><U>&nbsp;14</U> of this <U>Article II</U>) to the secretary at the principal executive offices of the Corporation a written
questionnaire providing the information requested about the background and qualifications of such person and the background of any other person or entity on whose behalf the nomination is being made and a written representation and agreement (the
questionnaire, representation, and agreement to be in the form provided by the secretary upon written request) that such person: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is not and will not become a party to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person
or entity as to how the person, if elected as a director of the Corporation, will act or vote on any issue or question (a &#147;Voting Commitment&#148;) that has not been disclosed to the Corporation, or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Voting Commitment that could limit or interfere with the person&#146;s ability to comply, if elected as a
director of the Corporation, with the person&#146;s fiduciary duties under applicable law, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is not and will not become a party to any agreement, arrangement or understanding with any person or entity
other than the Corporation with respect to any direct or indirect compensation, reimbursement, or indemnification in connection with service or action as a director that has not been disclosed therein, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the person&#146;s individual capacity and on behalf of any person or entity on whose behalf the nomination
is being made, would be in compliance, if elected as a director of the Corporation, and will comply with all applicable publicly disclosed corporate governance, conflict of interest, confidentiality, and stock ownership and trading policies and
guidelines of the Corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">F. Only such persons who are nominated in accordance with the procedures set forth in
this <U>Section</U><U></U><U>&nbsp;11</U> and, if applicable, <U>Section</U><U></U><U>&nbsp;14</U> of this Article II shall be eligible to serve as directors. Only such business shall be conducted at a meeting of stockholders as shall have been
brought before the meeting in accordance with the procedures set forth in this <U>Section</U><U></U><U>&nbsp;11</U>. The chairman of the meeting shall determine whether any nominee or business proposed to be transacted by the stockholders has been
properly brought before the meeting and, if any nominee or proposed business has not been properly brought before the meeting, the chairman shall declare that such nominee shall not be considered for election or such proposed business shall not be
presented for stockholder action at the meeting. Notwithstanding the foregoing provisions of this <U>Section</U><U></U><U>&nbsp;11</U>, unless otherwise required by law, if the stockholder does not provide the supplemental information required
regarding both the stockholder and any Stockholder Associated Persons under <U>Section</U><U></U><U>&nbsp;11(D)(ii)</U> or if the stockholder (or a qualified representative of the stockholder) does not appear at the annual meeting to present the
nominee or proper business described in the Stockholder Notice, such nominee shall not be presented for election or such business shall not be transacted, notwithstanding that proxies in respect of such election or such business may have been
received by the Corporation. For purposes of this <U>Section</U><U></U><U>&nbsp;11</U>, to be considered a &#147;qualified representative&#148; of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or
must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as a proxy at the meeting and such person must produce such writing or electronic transmission, or a
reliable reproduction of the writing or electronic transmission, at the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">G. As referred to herein, &#147;Public Disclosure&#148;
shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or a comparable national news service or the filing of information with the Securities and Exchange Commission via the EDGAR filing system. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">H. As referred to herein, &#147;Stockholder Associated Person&#148; of any stockholder means (i)&nbsp;any person controlling, directly or
indirectly, or acting in concert with, such stockholder, (ii)&nbsp;any beneficial owner of shares of any class or series of stock of the Corporation owned of record or beneficially by such stockholder and (iii)&nbsp;any person controlling,
controlled by or under common control with such Stockholder Associated Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I. The foregoing notice requirements of this
<U>Section</U><U></U><U>&nbsp;11</U> shall be deemed satisfied by a stockholder with respect to business other than a nomination if the stockholder has notified the Corporation of his, her or its intention to present a proposal at an annual meeting
in compliance with applicable rules and regulations promulgated under the Exchange Act and such stockholder&#146;s proposal has been included in a proxy statement that has been prepared by the Corporation to solicit proxies for such annual meeting.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">J. Notwithstanding anything to the contrary contained in this
<U>Section</U><U></U><U>&nbsp;11</U>, for as long as the Stockholders&#146; Agreement dated as of March&nbsp;9, 2011 among the Corporation, Hercules Holding II and affiliates of various equity sponsors (as may be amended, supplemented or modified
from time to time, the &#147;Stockholders&#146; Agreement&#148;) remains in effect, no Investor Group (as defined in the Stockholders&#146; Agreement) that has the right to nominate a person to be elected to the Board of Directors pursuant to the
Stockholders&#146; Agreement shall be subject to the procedures of this <U>Section</U><U></U><U>&nbsp;11</U> or <U>Section</U><U></U><U>&nbsp;14</U> of this <U>Article II</U> to nominate any such person to be elected to the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">K. Notwithstanding the foregoing provisions of this <U>Section</U><U></U><U>&nbsp;11</U>, unless otherwise required by applicable law, if any
Proponent (i)&nbsp;provides notice pursuant to Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT> promulgated under the Exchange Act and (ii)&nbsp;subsequently fails to comply with the requirements of Rule
<FONT STYLE="white-space:nowrap">14a-19(a)(2)</FONT> and Rule <FONT STYLE="white-space:nowrap">14a-19(a)(3)</FONT> promulgated under the Exchange Act, then the Corporation shall disregard the proposed nomination of a person or persons for election
to the Board of Directors and any proxies or votes solicited for any director nominee proposed by such Proponent. Upon request by the Corporation, any Proponent that has provided notice pursuant to Rule
<FONT STYLE="white-space:nowrap">14a-19(b)</FONT> promulgated under the Exchange Act shall deliver to the Corporation, no later than five (5)&nbsp;business days prior to the applicable meeting, reasonable evidence that it has met the requirements of
Rule <FONT STYLE="white-space:nowrap">14a-19(a)(3)</FONT> promulgated under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 12.</B><B> </B><B>ACTION BY
WRITTEN CONSENT.</B> Any action required or permitted to be taken at any annual or special meeting of stockholders of the Corporation may be taken only upon the vote of the stockholders at an annual or special meeting duly called and may not be
taken by written consent of the stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 13.</B><B> </B><B>FIXING A RECORD DATE.</B> In order that the Corporation may
determine the stockholders entitled to notice of any meeting of stockholders or any adjournment thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is
adopted by the Board of Directors, and which record date shall, unless otherwise required by law, not be more than sixty (60)&nbsp;nor less than ten (10)&nbsp;days before the date of such meeting. If the Board of Directors so fixes a date, such date
shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board of Directors determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date
for making such determination. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next
preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of
stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the
record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of
any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix a record date, which shall not be more than sixty (60)&nbsp;days
prior to such other action. If no such record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 14. PROXY ACCESS FOR DIRECTOR NOMINATIONS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. With respect to the election of directors at an annual meeting of stockholders, subject to the provisions of this
<U>Section</U><U></U><U>&nbsp;14</U> and <U>Section</U><U></U><U>&nbsp;11</U> of this <U>Article II</U> (as applicable), the Corporation shall include in its proxy statement (including its form of proxy) for such annual meeting, in addition to any
persons nominated for election by the Board of Directors, the name, together with the &#147;Proxy Access Required Information,&#148; of any person or persons, as applicable, nominated for election to the Board of Directors (the &#147;Stockholder
Nominee(s)&#148;), each of whom satisfies the requirements of this <U>Section</U><U></U><U>&nbsp;14</U> and <U>Section</U><U></U><U>&nbsp;11</U> of this <U>Article</U><U></U><U>&nbsp;II</U> (as applicable) and the director qualification requirements
set forth in the Corporation&#146;s Corporate Governance Guidelines and any other document(s) setting forth qualifications for directors, by an individual eligible stockholder or group of up to twenty (20)&nbsp;eligible stockholders (such eligible
stockholder or eligible members of a group, the &#147;Proxy Access Eligible Stockholder&#148;) who expressly elects in writing at the time of providing the notice required by this <U>Section</U><U></U><U>&nbsp;14</U> (the &#147;Proxy Access
Notice&#148;) to have its nominee or nominees, as applicable, included in the Corporation&#146;s proxy materials pursuant to this <U>Section</U><U></U><U>&nbsp;14</U>; provided, however, that a stockholder that has a contractual right to designate
one or more nominees for director shall not be, and any of such stockholder&#146;s respective affiliates or associates and/or any others acting in concert with any of the foregoing shall not be, a Proxy Access Eligible Stockholder and shall not be
eligible to participate in a group of stockholders constituting a Proxy Access Eligible Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. To be timely for purposes of this
<U>Section</U><U></U><U>&nbsp;14</U>, the Proxy Access Notice must be made by notice in writing delivered to, or mailed and received by, the secretary of the Corporation at the principal executive offices of the Corporation no earlier than one
hundred fifty (150)&nbsp;days and no later than one hundred twenty (120)&nbsp;days prior to the first anniversary of the date that the Corporation mailed its proxy statement for the preceding year&#146;s annual meeting of stockholders; provided,
however, that in the event that no annual meeting of stockholders was held in the previous year or the annual meeting of stockholders is called for a date that is not within thirty (30)&nbsp;days before or after such anniversary date, such Proxy
Access Notice shall be made by notice in writing delivered to, or mailed and received by, the secretary of the Corporation no later than ninety (90)&nbsp;days prior to such annual meeting of stockholders or, if later, ten (10)&nbsp;days following
the day on which notice of the date of the meeting was mailed or Public Disclosure of the date of such annual meeting of stockholders was first made, whichever occurs first. In no event will an adjournment or postponement of an annual meeting of
stockholders or the announcement thereof commence a new time period for the giving of a Proxy Access Notice as provided above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. The
maximum number of Stockholder Nominees nominated by all Proxy Access Eligible Stockholders that will be required to be included in the Corporation&#146;s proxy materials with respect to an annual meeting of stockholders shall not exceed the greater
of (i)&nbsp;two (2) or (ii)&nbsp;the Specified Percentage of the number of directors in office as of the last day on which a Proxy Access Notice may be timely delivered pursuant to and in accordance with this <U>Section</U><U></U><U>&nbsp;14</U>
(the &#147;Final Proxy Access Nomination Date&#148;), rounded down to the closest whole number below the Specified Percentage if such amount is not a whole number; provided, however, that the maximum number of Stockholder Nominees shall be reduced
by (1)&nbsp;the number of director candidates for which the Corporation shall have received one or more valid Stockholder Notices pursuant to <U>Section</U><U></U><U>&nbsp;11</U> of this <U>Article II</U>, (2)&nbsp;the number of director candidates
that the Board of Directors nominates pursuant to an agreement, arrangement or other understanding with one or more stockholders in lieu of such director candidates being formally nominated pursuant to this <U>Section</U><U></U><U>&nbsp;14</U>, (3)
the number of directors in office that will be included in the Corporation&#146;s proxy materials with respect to such annual meeting of stockholders for whom access to the Corporation&#146;s proxy materials was previously provided pursuant to this
<U>Section</U><U></U><U>&nbsp;14</U>, other than any such director referred to in clause (2)&nbsp;or this clause (3)&nbsp;who, at the time of such annual meeting of stockholders, will have served as a director continuously as a nominee of the Board
of Directors for at least three annual terms and (4)&nbsp;the number of Stockholder Nominees whose names were submitted for inclusion in the Corporation&#146;s proxy materials </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pursuant to this <U>Section</U><U></U><U>&nbsp;14</U> but who were subsequently withdrawn or who the Board of Directors decides to nominate as Board of Director nominees. In the event that one or
more vacancies for any reason occurs on the Board of Directors after the Final Proxy Access Nomination Date but before the date of the annual meeting of stockholders and the Board of Directors resolves to reduce the size of the Board of Directors in
connection therewith, the maximum number of Stockholder Nominees included in the Corporation&#146;s proxy materials shall be calculated based on the number of directors in office as so reduced. Any Proxy Access Eligible Stockholder submitting more
than one Stockholder Nominee for inclusion in the Corporation&#146;s proxy materials pursuant to this <U>Section</U><U></U><U>&nbsp;14</U> shall rank such Stockholder Nominees based on the order that the Proxy Access Eligible Stockholder desires
such Stockholder Nominees to be selected for inclusion in the Corporation&#146;s proxy statement in the event that the total number of Stockholder Nominees submitted by Proxy Access Eligible Stockholders pursuant to this
<U>Section</U><U></U><U>&nbsp;14</U> exceeds the maximum number of nominees provided for in this <U>Section</U><U></U><U>&nbsp;14</U>. In the event that the number of Stockholder Nominees submitted by Proxy Access Eligible Stockholders pursuant to
this <U>Section</U><U></U><U>&nbsp;14</U> exceeds the maximum number of nominees provided for in this <U>Section</U><U></U><U>&nbsp;14</U>, the highest ranking Stockholder Nominee who meets the requirements of this
<U>Section</U><U></U><U>&nbsp;14</U> from each Proxy Access Eligible Stockholder will be selected for inclusion in the Corporation&#146;s proxy materials until the maximum number is reached, going in order of the amount (largest to smallest) of
shares of capital stock of the Corporation each Proxy Access Eligible Stockholder disclosed as owned in its respective Proxy Access Notice submitted to the Corporation. If the maximum number is not reached after the highest ranking Stockholder
Nominee who meets the requirements of this <U>Section</U><U></U><U>&nbsp;14</U> from each Proxy Access Eligible Stockholder has been selected, this process will continue as many times as necessary, following the same order each time, until the
maximum number is reached. Notwithstanding anything to the contrary contained in this <U>Section</U><U></U><U>&nbsp;14</U>, if the Corporation receives notice pursuant to <U>Section</U><U></U><U>&nbsp;11</U> of this <U>Article II</U> that a
stockholder intends to nominate for election at such meeting a number of nominees greater than or equal to a majority of the total number of directors to be elected at such meeting, no Stockholder Nominees will be included in the Corporation&#146;s
proxy materials with respect to such meeting pursuant to this <U>Section</U><U></U><U>&nbsp;14</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. For purposes of this
<U>Section</U><U></U><U>&nbsp;14</U>: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the term &#147;Affiliates&#148; shall have the meaning ascribed to it in Rule
<FONT STYLE="white-space:nowrap">12b-2</FONT> under the Exchange Act, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the &#147;Minimum Holding Period&#148; is three (3)&nbsp;years, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the &#147;Proxy Access Required Information&#148; that the Corporation will include in its proxy statement is
the information provided to the secretary of the Corporation concerning the Stockholder Nominee(s) and the Proxy Access Eligible Stockholder that is required to be disclosed in the Corporation&#146;s proxy statement by Section&nbsp;14 of the
Exchange Act, and the rules and regulations promulgated thereunder, and, if the Proxy Access Eligible Stockholder so elects, a written statement, not to exceed 500 words, in support of the Stockholder Nominee(s)&#146; candidacy (the
&#147;Statement&#148;). Notwithstanding anything to the contrary contained in this <U>Section</U><U></U><U>&nbsp;14</U>, the Corporation may omit from its proxy materials any information or Statement (or portion thereof) that it, in good faith,
believes would violate any applicable law, rule, regulation or listing standard, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iv.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the &#147;Required Ownership Percentage&#148; is 3% or more, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">v.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the &#147;Specified Percentage&#148; is 20%, and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">vi.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Proxy Access Eligible Stockholder shall be deemed to &#147;own&#148; only those outstanding shares of capital
stock of the Corporation as to which the stockholder possesses both (a)&nbsp;the full voting and investment rights pertaining to the shares and (b)&nbsp;the full economic interest in (including the opportunity for profit from and risk of loss on)
such shares; provided, that the number of shares calculated in accordance with clauses (a)&nbsp;and (b) shall not include any shares (1)&nbsp;sold by such stockholder or any of its Affiliates in any transaction that has not been settled or closed,
(2)&nbsp;borrowed by such stockholder or any of its Affiliates for any purposes or purchased by such stockholder or any of its Affiliates pursuant to an agreement to resell or (3)&nbsp;subject to any option, warrant, forward contract, swap, contract
of sale, other derivative or similar agreement entered into by such stockholder or any of its Affiliates, whether any such instrument or agreement is to be settled with shares of capital stock of the Corporation or with cash based on the notional
amount or value of shares of outstanding capital stock of the Corporation subject thereto, in any such case which instrument or agreement has, or is intended to have, the purpose or effect of (A)&nbsp;reducing in any manner, to any extent or at any
time in the future, such stockholder&#146;s or its Affiliates&#146; full right to vote or direct the voting of any such shares, and/or (B)&nbsp;hedging, offsetting or altering to any degree any gain or loss realized or realizable arising from
maintaining the full economic ownership of such shares by such stockholder or Affiliate. For purposes of this <U>Section</U><U></U><U>&nbsp;14</U>, a stockholder shall &#147;own&#148; shares held in the name of its bank, broker or other nominee or
intermediary so long as the stockholder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares through the annual meeting date. A stockholder&#146;s
ownership of shares shall be deemed to continue during any period in which the stockholder has delegated any voting power by means of a proxy, power of attorney or other instrument or arrangement which is revocable at any time by the stockholder. A
stockholder&#146;s ownership of shares shall be deemed to continue during any period in which the stockholder has loaned such shares, provided that the person has the power to recall such loaned shares on no more than five (5)&nbsp;business
days&#146; notice and (x)&nbsp;will promptly recall such loaned shares upon being notified that any of its Stockholder Nominees will be included in the Corporation&#146;s proxy materials and (y)&nbsp;will continue to hold such recalled shares
through the annual meeting date. The terms &#147;owned,&#148; &#147;owning&#148; and other variations of the word &#147;own&#148; shall have correlative meanings. Whether outstanding shares of capital stock of the Corporation are &#147;owned&#148;
for these purposes shall be determined by the Board of Directors or any committee thereof, which determination shall be conclusive and binding on the Corporation and its stockholders. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. In order to make a nomination pursuant to this <U>Section</U><U></U><U>&nbsp;14</U>, a Proxy Access Eligible Stockholder must have owned the
Required Ownership Percentage of the outstanding shares of capital stock of the Corporation entitled to vote in the election of directors (the &#147;Required Shares&#148;) continuously for the Minimum Holding Period as of both (1)&nbsp;the date the
Proxy Access Notice is delivered to or mailed to and received by the secretary of the Corporation in accordance with this <U>Section</U><U></U><U>&nbsp;14</U> and (2)&nbsp;the record date for determining the stockholders entitled to vote at the
annual meeting of stockholders, and must continue to own the Required Shares through such annual meeting date. A Proxy Access Eligible Stockholder shall certify in its Proxy Access Notice the number of eligible shares of outstanding capital stock of
the Corporation it asserts it is deemed to own for the purposes of this <U>Section</U><U></U><U>&nbsp;14</U>. The aggregate number of stockholders whose collective stock ownership may be counted for the purpose of satisfying the Required Ownership
Percentage shall not exceed twenty (20), and no stockholder may be a member of more than one group under this <U>Section</U><U></U><U>&nbsp;14</U>. Two or more funds that are part of the same family of funds under common management and investment
control (a &#147;Qualifying Fund Family&#148;) shall be treated as one </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholder for the purpose of determining the aggregate number of stockholders under this <U>Section</U><U></U><U>&nbsp;14</U>. No later than the end of the time period specified in this
<U>Section</U><U></U><U>&nbsp;14</U> for delivering the Proxy Access Notice, a Qualifying Fund Family whose stock ownership is counted for purposes of qualifying as a Proxy Access Eligible Stockholder must provide to the secretary of the Corporation
documentation reasonably satisfactory to the Board of Directors, or any committee thereof, that demonstrates that the funds comprising the Qualifying Fund Family satisfy the definition thereof. Within the time period specified in this
<U>Section</U><U></U><U>&nbsp;14</U> for delivering the Proxy Access Notice, a Proxy Access Eligible Stockholder (including each stockholder, whether individually or as a member of an eligible group, and each fund comprising a Qualifying Fund
Family) must provide the following information in writing to the secretary of the Corporation: (i)&nbsp;one or more written statements from the record holder of the shares (and from each intermediary through which the shares are or have been held
during the Minimum Holding Period) verifying that, as of a date within seven (7)&nbsp;calendar days prior to the date the Proxy Access Notice is delivered to or mailed to and received by the secretary of the Corporation, the Proxy Access Eligible
Stockholder owns, and has owned continuously for the Minimum Holding Period, the Required Shares, and the Proxy Access Eligible Stockholder&#146;s agreement to provide, within five (5)&nbsp;business days after the record date for the annual meeting
of stockholders, written statements from the record holder and intermediaries verifying the Proxy Access Eligible Stockholder&#146;s continuous ownership of the Required Shares through the record date; (ii)&nbsp;a copy of the Schedule 14N that has
been filed with the Securities and Exchange Commission as required by Rule <FONT STYLE="white-space:nowrap">14a-18</FONT> under the Exchange Act; (iii)&nbsp;the information and representations that are the same as those that would be required to be
set forth in a Stockholder Notice of nomination pursuant to <U>Section</U><U></U><U>&nbsp;11</U> of this <U>Article II</U>; (iv)&nbsp;the consent of each Stockholder Nominee to being named in the Corporation&#146;s proxy statement as a nominee and
to serving as a director if elected; (v)&nbsp;a representation that the Proxy Access Eligible Stockholder (a)&nbsp;acquired the Required Shares in the ordinary course of business and not with the intent to change or influence control at the
Corporation, and does not have any such intent, (b)&nbsp;will maintain qualifying ownership of the Required Shares through the date of the annual meeting of stockholders, (c)&nbsp;has not engaged and will not engage in, and has not and will not be a
&#147;participant&#148; in another person&#146;s, &#147;solicitation&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">14a-1(l)</FONT> under the Exchange Act in support of the election of any individual as a director at the annual
meeting of stockholders other than its Stockholder Nominee(s) or a nominee of the Board of Directors, (d)&nbsp;will not distribute to any stockholder any form of proxy for the meeting other than the form distributed by the Corporation, (e)&nbsp;has
not nominated and will not nominate for election any individual as a director at the annual meeting of stockholders other than its Stockholder Nominee(s), (f) agrees to comply with all applicable laws, rules and regulations with respect to any
solicitation in connection with the meeting and will file with the Securities and Exchange Commission any solicitation or other communication with the Corporation&#146;s stockholders relating to the meeting at which the Stockholder Nominee will be
nominated, regardless of whether any such filing is required under Regulation 14A of the Exchange Act or an exemption from filing is available thereunder, and (g)&nbsp;will provide facts, statements and other information in all communications with
the Corporation and its stockholders that are or will be true and correct in all material respects and do not and will not omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they
were made, not misleading; (vi)&nbsp;an undertaking that the Proxy Access Eligible Stockholder agrees to (a)&nbsp;assume all liability stemming from any legal or regulatory violation arising out of the Proxy Access Eligible Stockholder&#146;s
communications with the stockholders of the Corporation or out of the information that the Proxy Access Eligible Stockholder provided to the Corporation and (b)&nbsp;indemnify and hold harmless the Corporation and each of its directors, officers and
employees individually against any liability, loss or damages in connection with any threatened or pending action, suit or proceeding, whether legal, administrative or investigative, against the Corporation or any of its directors, officers or
employees arising out of any nomination submitted and/or efforts to have its Stockholder Nominee(s) elected by the Proxy Access Eligible Stockholder pursuant to this <U>Section</U><U></U><U>&nbsp;14</U>; and (vii)&nbsp;in the case of a nomination
under this <U>Section</U><U></U><U>&nbsp;14</U> by a group of stockholders, the designation by all group members of one group member that is authorized to act on behalf of all members of the nominating stockholder group with respect to the
nomination and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
matters related thereto, including withdrawal of the nomination. For the avoidance of doubt, in the event that the Proxy Access Eligible Stockholder consists of a group of stockholders, the
requirements and obligations applicable to an individual Proxy Access Eligible Stockholder that are set forth in these Bylaws, including the Minimum Holding Period, shall apply to each member of such group individually; provided, however, that the
Required Ownership Percentage shall apply to the continuous ownership of the eligible group in the aggregate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">F. In the event that any
information or communications provided by the Proxy Access Eligible Stockholder or any Stockholder Nominee(s) to the Corporation or its stockholders ceases to be true and correct in all material respects or omits a material fact necessary to make
the statements made, in light of the circumstances under which they were made, not misleading, each Proxy Access Eligible Stockholder or Stockholder Nominee, as the case may be, shall promptly notify the secretary of the Corporation of any defect in
such previously provided information and of the information that is required to correct any such defect; it being understood that providing any such notification shall not be deemed to cure any such defect or limit the remedies (including without
limitation under these Bylaws) available to the Corporation relating to any such defect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">G. The Corporation shall not be required to
include, pursuant to this <U>Section</U><U></U><U>&nbsp;14</U>, a Stockholder Nominee in its proxy materials for any meeting of stockholders (i)&nbsp;whose election as a member of the Board of Directors would cause the Corporation to be in violation
of these Bylaws, the Certificate of Incorporation, the rules and listing standards of the principal U.S. exchanges upon which the shares of capital stock of the Corporation are traded, or any applicable state or federal law, rule or regulation, or
any of the Corporation&#146;s publicly disclosed standards or qualifications applicable to its directors; (ii)&nbsp;for which the secretary of the Corporation receives a notice that a stockholder has nominated such Stockholder Nominee for election
to the Board of Directors pursuant to the advance notice requirements for stockholder nominees for director set forth in <U>Section</U><U></U><U>&nbsp;11</U> of this <U>Article II</U>; (iii)&nbsp;who is not independent as determined by the Board of
Directors under (a)&nbsp;the listing standards of each principal U.S. exchange upon which the shares of capital stock of the Corporation are listed, (b)&nbsp;any applicable rules of the Securities and Exchange Commission and (c)&nbsp;any publicly
disclosed standards used by the Board of Directors in determining independence of the Corporation&#146;s directors; (iv)&nbsp;if the Proxy Access Eligible Stockholder that has nominated such Stockholder Nominee or any such Stockholder Nominee has
engaged in or is currently engaged in, or has been or is a &#147;participant&#148; in another person&#146;s, &#147;solicitation&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">14a-1(l)</FONT> under the Exchange Act in support of
the election of any individual as a director at the annual meeting of stockholders other than the Proxy Access Eligible Stockholder&#146;s Stockholder Nominee(s) or a nominee of the Board of Directors; (v)&nbsp;if the Stockholder Nominee is or
becomes a party to any compensatory, payment, reimbursement, indemnification or other financial agreement, arrangement or understanding with any person or entity other than the Corporation, or is receiving or will receive any such compensation,
payment, reimbursement or indemnification from any person or entity other than the Corporation, in each case, in connection with service as a director of the Corporation; (vi)&nbsp;if the Stockholder Nominee is or becomes a party to any Voting
Commitment; (vii)&nbsp;who is or has been, within the past three years, an officer or director of a competitor, as defined in Section&nbsp;8 of the Clayton Antitrust Act of 1914; (viii) who is a named subject of a pending criminal proceeding
(excluding traffic violations and other minor offenses) or has been convicted in such a criminal proceeding within the past ten (10)&nbsp;years; (ix) who is subject to any order of the type specified in Rule 506(d) of Regulation D promulgated under
the Securities Act of 1933, as amended; (x)&nbsp;if such Stockholder Nominee or the applicable Proxy Access Eligible Stockholder shall have provided information to the Corporation in respect to such nomination that was untrue in any material respect
or omitted to state a material fact necessary in order to make the statement(s) made, in light of the circumstances under which they were made, not misleading, as determined by the Board of Directors or any committee thereof; (xi)&nbsp;whose
then-current or prior business or personal interests place such Stockholder Nominee in a conflict of interest with the Corporation or any of its subsidiaries that would cause such Stockholder Nominee to violate any fiduciary duties of directors
established pursuant to applicable law; or (xii)&nbsp;the Proxy Access Eligible Stockholder or applicable Stockholder Nominee fails to comply with its obligations, agreements, representations and/or undertakings pursuant to these Bylaws, including
this <U>Section</U><U></U><U>&nbsp;14</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">H. Any Stockholder Nominee who is included in the Corporation&#146;s proxy materials for a
particular annual meeting of stockholders but either (i)&nbsp;does not receive at least 25% of the votes cast in favor of such Stockholder Nominee&#146;s election or (ii)&nbsp;becomes ineligible or unavailable for or withdraws from election at the
annual meeting of stockholders, will be ineligible to be a Stockholder Nominee pursuant to this <U>Section</U><U></U><U>&nbsp;14</U> for the next two annual meetings of stockholders. Any Proxy Access Eligible Stockholder (including each stockholder
or fund comprising a Qualifying Fund Family whose stock ownership is counted for the purposes of qualifying as a Proxy Access Eligible Stockholder) whose Stockholder Nominee is elected as a director at an annual meeting of stockholders will not be
eligible to nominate or participate in the nomination of a Stockholder Nominee for the following two annual meetings of stockholders other than the nomination of such previously elected Stockholder Nominee in accordance with this
<U>Section</U><U></U><U>&nbsp;14</U>. Notwithstanding anything to the contrary set forth herein, the Board of Directors or the presiding officer of the annual meeting of stockholders shall declare a nomination by a Proxy Access Eligible Stockholder
to be invalid, and such nomination shall be disregarded notwithstanding that proxies in respect of such vote may have been received by the Corporation, if (i)&nbsp;the Stockholder Nominee(s) and/or the applicable Proxy Access Eligible Stockholder
shall have breached its or their obligations under this <U>Section</U><U></U><U>&nbsp;14</U>, as determined by the Board of Directors or such presiding officer or (ii)&nbsp;the Proxy Access Eligible Stockholder (or a qualified representative
thereof) does not appear at the meeting of stockholders to present any nomination pursuant to this <U>Section</U><U></U><U>&nbsp;14</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I. Except for a nomination made in accordance with both <U>Section</U><U></U><U>&nbsp;11</U> and Rule
<FONT STYLE="white-space:nowrap">14a-19</FONT> promulgated under the Exchange Act, this <U>Section</U><U></U><U>&nbsp;14</U> shall be the exclusive method for stockholders to include nominees for director in the Corporation&#146;s proxy materials.
For the avoidance of doubt, the Corporation may in its sole discretion solicit against, and include in the proxy statement its own statements or other information relating to, any Proxy Access Eligible Stockholder and/or stockholder director
nominees (including any Stockholder Nominee) for director, including any information provided to the Corporation with respect to the foregoing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DIRECTORS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 1.</B><B> </B><B>GENERAL POWERS.</B> The business and affairs of the Corporation shall be managed by or under the direction of the
Board of Directors. The Board of Directors may exercise all such authority and powers of the Corporation and do all such lawful acts and things as are not by the General Corporation Law of the State of Delaware or the Certificate of Incorporation
directed or required to be exercised or done by the stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.</B><B> </B><B>ANNUAL MEETINGS.</B> Unless the Board of
Directors shall otherwise provide, the annual meeting of the Board of Directors shall be held without other notice than this Bylaw immediately after, and at the same place, if any, as, the annual meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.</B><B> </B><B>REGULAR MEETINGS AND SPECIAL MEETINGS.</B> Regular meetings of the Board of Directors, other than the annual
meeting, may be held without notice at such time and at such place, if any, as shall from time to time be determined by the Board of Directors. Special meetings of the Board of Directors may be called by the chairman of the board, the chief
executive officer (if the chief executive officer is a director) or upon the written request of at least a majority of the directors then in office. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.</B><B> </B><B>NOTICE OF MEETINGS.</B> Notice of regular meetings of the Board
of Directors need not be given except as otherwise required by law or these Bylaws. Notice of each special meeting of the Board of Directors, and of each regular and annual meeting of the Board of Directors for which notice shall be required, shall
be given by the secretary as hereinafter provided in this <U>Section</U><U></U><U>&nbsp;4</U>, in which notice shall be stated the date, time and place, if any, of the meeting. Except as otherwise required by these Bylaws, such notice need not state
the purposes of such meeting. Notice of any special meeting, and of any regular or annual meeting for which notice is required, shall be given to each director at least (a)&nbsp;twenty-four (24)&nbsp;hours before the meeting if by telephone or by
being personally delivered or sent by facsimile transmission, <FONT STYLE="white-space:nowrap">e-mail</FONT> or other form of wire, wireless, or other means of electronic transmission or (b)&nbsp;five (5)&nbsp;days before the meeting if delivered by
mail to the director&#146;s residence or usual place of business. Such notice shall be deemed to be delivered when deposited in the United States mail so addressed, with postage prepaid, or when transmitted if sent by facsimile transmission, <FONT
STYLE="white-space:nowrap">e-mail</FONT> or other form of wire, wireless, or other means of electronic transmission. Neither the business to be transacted at, nor the purpose of, any special meeting of the Board of Directors need be specified in the
notice or waiver of notice of such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.</B><B> </B><B>WAIVER OF NOTICE AND PRESUMPTION OF ASSENT.</B> Any director may
waive notice of any meeting by a written waiver signed by the director entitled to the notice or a waiver by electronic transmission by the director entitled to the notice. Any member of the Board of Directors or any committee thereof who is present
at a meeting shall be conclusively presumed to have waived notice of such meeting except when such member attends for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not
lawfully called or convened. Such member shall be conclusively presumed to have assented to any action taken unless his or her dissent shall be entered in the minutes of the meeting or unless his or her written dissent to such action shall be filed
with the person acting as the secretary of the meeting before the adjournment thereof or shall be forwarded by registered mail to the secretary of the Corporation immediately after the adjournment of the meeting. Such right to dissent shall not
apply to any member who voted in favor of such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.</B><B> </B><B>CHAIRMAN OF THE BOARD, QUORUM, REQUIRED VOTE AND
ADJOURNMENT.</B> The Board of Directors shall elect, by the affirmative vote of a majority of the total number of directors then in office, a chairman of the board, who shall preside at all meetings of the stockholders and Board of Directors at
which he or she is present and shall have such powers and perform such duties as the Board of Directors may from time to time prescribe. If the chairman of the board is not present at a meeting of stockholders or the Board of Directors, the chief
executive officer (if the chief executive officer is a director and is not also the chairman of the board) shall preside at such meeting, and, if the chief executive officer is not present at such meeting or is not a director, a majority of the
directors present at such meeting shall elect one (1)&nbsp;of their members to so preside. A majority of the total number of directors then in office shall constitute a quorum for the transaction of business. Unless by express provision of an
applicable law, the Certificate of Incorporation or these Bylaws a different vote is required, the vote of a majority of directors present at a meeting at which a quorum is present shall be the act of the Board of Directors. If a quorum shall not be
present at any meeting of the Board of Directors, a majority of the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.</B><B> </B><B>COMMITTEES.</B> The Board of Directors (i)&nbsp;may, by resolution passed by the Board of Directors, designate one
or more committees, including an executive committee, consisting of one or more of the directors of the Corporation, and (ii)&nbsp;shall during such period of time as any securities of the Corporation are listed on a securities exchange, by
resolution passed by the Board of Directors, designate all committees required by the rules and regulations of the principal U.S. exchange upon which the shares of capital stock of the Corporation are listed. The Board of Directors may designate one
or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. Except to the extent restricted by applicable law or the Certificate of Incorporation, each
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such committee, to the extent provided in the resolution creating it, shall have and may exercise all the powers and authority of the Board of Directors. Each such committee shall serve at the
pleasure of the Board of Directors as may be determined from time to time by resolution adopted by the Board of Directors or as required by the rules and regulations of the principal U.S. exchange upon which the shares of capital stock of the
Corporation are listed, if applicable. Each committee shall keep regular minutes of its meetings and report the same to the Board of Directors upon request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 8.</B><B> </B><B>COMMITTEE RULES.</B> Each committee of the Board of Directors may fix its own rules of procedure and shall hold
its meetings as provided by such rules, except as may otherwise be provided by a resolution of the Board of Directors designating such committee. Unless otherwise provided in such a resolution, the presence of at least a majority of the members of
the committee shall be necessary to constitute a quorum. Unless otherwise provided in such a resolution, in the event that a member and that member&#146;s alternate, if alternates are designated by the Board of Directors, of such committee is or are
absent or disqualified, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the
meeting in place of any such absent or disqualified member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 9.</B><B> </B><B>COMMUNICATIONS EQUIPMENT.</B> Members of the
Board of Directors or any committee thereof may participate in and act at any meeting of such board or committee through the use of a conference telephone or other communications equipment by means of which all persons participating in the meeting
can hear and speak with each other, and participation in the meeting pursuant to this <U>Section</U><U></U><U>&nbsp;9</U> shall constitute presence in person at the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 10.</B><B> </B><B>ACTION BY WRITTEN CONSENT.</B> Unless otherwise restricted by the Certificate of Incorporation, any action
required or permitted to be taken at any meeting of the Board of Directors, or of any committee thereof, may be taken without a meeting if all members of such board or committee, as the case may be, consent thereto in accordance with applicable law,
and the writing or other evidence (including electronic transmission) of such consent is filed with the minutes of proceedings of the Board of Directors or committee, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 11.</B><B> </B><B>RESIGNATIONS; NEWLY CREATED DIRECTORSHIPS; VACANCIES; AND REMOVALS.</B> Any director of the Corporation may
resign at any time by giving notice in writing or by electronic transmission of his resignation to the Corporation. Except as contemplated by <U>Section</U><U></U><U>&nbsp;2</U> of <U>Article II</U> of these Bylaws, any such resignation shall take
effect at the time specified therein or, if the time when it shall become effective shall not be specified therein, immediately upon its receipt. Unless otherwise specified therein or as contemplated by <U>Section</U><U></U><U>&nbsp;2</U> of
<U>Article II</U> of these Bylaws, the acceptance of such resignation shall not be necessary to make it effective. Newly created directorships resulting from any increase in the number of directors or any vacancies in the Board of Directors
resulting from death, resignation, retirement, disqualification, removal or any other cause shall be filled as provided in the Certificate of Incorporation. Any director may be removed as provided in the Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 12.</B><B> </B><B>COMPENSATION.</B> The Board of Directors shall have the authority to fix the compensation, including fees and
reimbursement of expenses, of directors for services to the Corporation in any capacity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 13.</B><B> </B><B>RELIANCE ON BOOKS
AND RECORDS.</B> A member of the Board of Directors, or a member of any committee designated by the Board of Directors shall, in the performance of such person&#146;s duties, be fully protected in relying in good faith upon records of the
Corporation and upon such information, opinions, reports or statements presented to the Corporation by any of the Corporation&#146;s officers or employees, or committees of the Board of Directors, or by any other person as to matters the member
reasonably believes are within such other person&#146;s professional or expert competence and who has been selected with reasonable care by or on behalf of the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>OFFICERS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 1.</B><B> </B><B>NUMBER.</B> The officers of the Corporation shall be elected by the Board of Directors and may include the
chairman of the board, the chief executive officer, the president, the chief financial officer, the chief operating officer, one or more group officers (including group presidents and group financial officers), one or more vice presidents (including
senior vice presidents, executive vice presidents or other classifications of vice presidents), the secretary and treasurer, and such other officers and assistant officers as may be deemed necessary or desirable by the Board of Directors. Any number
of offices may be held by the same person, except that neither the chief executive officer nor the president shall also hold the office of secretary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.</B><B> </B><B>ELECTION AND TERM OF OFFICE.</B> The officers of the Corporation shall be elected annually by the Board of
Directors. Vacancies may be filled or new offices created and filled at any meeting of the Board of Directors. Each officer shall hold office until a successor is duly elected and qualified or until his or her earlier death, resignation or removal
as hereinafter provided. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.</B><B> </B><B>RESIGNATIONS.</B> Any officer of the Corporation may resign at any time by giving
written notice of his or her resignation to the Corporation. Any such resignation shall take effect at the time specified therein or, if the time when it shall become effective shall not be specified therein, immediately upon receipt by the
Corporation. Unless otherwise specified therein, the acceptance of any such resignation shall not be necessary to make it effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.</B><B> </B><B>REMOVAL.</B> Any officer or agent elected by the Board of Directors may be removed by the Board of Directors at
its discretion, but such removal shall be without prejudice to the contract rights, if any, of the person so removed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION
5.</B><B> </B><B>VACANCIES.</B> Any vacancy occurring in any office because of death, resignation, removal, disqualification or otherwise may be filled by the Board of Directors. In its discretion, the Board of Directors may choose not to fill any
office for any period as it may deem advisable, except that the offices of chief executive officer and secretary shall be filled as expeditiously as possible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.</B><B> </B><B>COMPENSATION.</B> Compensation of all executive officers shall be approved by the Board of Directors, and no
officer shall be prevented from receiving such compensation by virtue of his or her also being a director of the Corporation; provided, however, that compensation of some or all executive officers may be determined by a committee established for
that purpose if so authorized by the Board of Directors or as required by applicable law or regulation, including any exchange or market upon which the Corporation&#146;s securities are then listed for trading or quotation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.</B><B> </B><B>CHIEF EXECUTIVE OFFICER.</B> The chief executive officer, subject to the Board of Directors, shall have general
executive charge, management, and control of the properties and operations of the Corporation in the ordinary course of its business, with all such powers with respect to such properties and operations as may be reasonably incident to such
responsibilities. If the Board of Directors has not elected a chairman or in the absence or inability to act of the chairman of the board, the chief executive officer shall exercise all of the powers and discharge all of the duties of the chairman
of the board, but only if the chief executive officer is a director of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 8.</B><B> </B><B>PRESIDENT.</B> The
president shall have the general powers and duties of supervision and management usually vested in the office of the president of a corporation and shall perform such other duties as the Board of Directors, the chairman of the board or the chief
executive officer may, from time to time, prescribe. At the request of the chief executive officer or in his or her absence or in the event of his or her inability or refusal to act, the president shall perform the duties of the chief executive
officer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 9.</B><B> </B><B>CHIEF OPERATING OFFICER</B>. The chief operating officer shall
have the general powers and duties of supervision and management usually vested in the office of the chief operating officer of a corporation and shall perform such other duties as the Board of Directors, the chairman of the board or the chief
executive officer may, from time to time, prescribe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 10.</B><B> </B><B>GROUP OFFICERS.</B> Each group officer shall perform
all such duties as from time to time may be assigned to him or her by the Board of Directors, the chairman of the board, the chief executive officer or the president. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 11.</B><B> </B><B>VICE-PRESIDENTS.</B> Each vice president shall perform all such duties as from time to time may be assigned to
him or her by the Board of Directors, the chairman of the board, the chief executive officer or the president. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 12.</B><B>
</B><B>SECRETARY AND ASSISTANT SECRETARIES.</B> The secretary shall attend all meetings of the Board of Directors (other than executive sessions thereof) and all meetings of the stockholders and record all the proceedings of the meetings in a book
or books to be kept for that purpose or shall ensure that his or her designee attends each such meeting to act in such capacity. Under the chairman of the board&#146;s supervision, the secretary shall give, or cause to be given, all notices required
to be given by these Bylaws or by law; shall have such powers and perform such duties as the Board of Directors, the chairman of the board, the chief executive officer, the president or these Bylaws may, from time to time, prescribe; and shall have
custody of the corporate seal of the Corporation. The secretary, or an assistant secretary, shall have authority to affix the corporate seal to any instrument requiring it and when so affixed, it may be attested by his or her signature or by the
signature of such assistant secretary. The Board of Directors may give general authority to any other officer to affix the seal of the Corporation and to attest the affixing by his or her signature. The assistant secretary, or if there be more than
one, any of the assistant secretaries, shall in the absence or disability of the secretary, perform the duties and exercise the powers of the secretary and shall perform such other duties and have such other powers as the Board of Directors, the
chairman of the board, the chief executive officer, the president or secretary may, from time to time, prescribe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 13.</B><B>
</B><B>CHIEF FINANCIAL OFFICER.</B> The chief financial officer shall have the custody of the corporate funds and securities; shall keep full and accurate all books and accounts of the Corporation as shall be necessary or desirable in accordance
with applicable law or generally accepted accounting principles; shall deposit all monies and other valuable effects in the name and to the credit of the Corporation as may be ordered by the chairman of the board or the Board of Directors; shall
cause the funds of the Corporation to be disbursed when such disbursements have been duly authorized, taking proper vouchers for such disbursements; and shall render to the Board of Directors, at its regular meeting or when the Board of Directors so
requires, an account of the financial condition of the Corporation; shall have such powers and perform such duties incident to the position of chief financial officer as the Board of Directors, the chairman of the board, the chief executive officer,
the president or these Bylaws may, from time to time, prescribe. The chief financial officer may also be the treasurer if so determined by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 14.</B><B> </B><B>OTHER OFFICERS, ASSISTANT OFFICERS AND AGENTS.</B> Officers, assistant officers and agents, if any, other than
those whose duties are provided for in these Bylaws, shall have such authority and perform such duties as may from time to time be assigned to him or her by the Board of Directors, the chairman of the board, the chief executive officer, the
president or a vice president. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 15.</B><B> </B><B>OFFICERS&#146; BONDS OR OTHER SECURITY.</B> If required by the
Board of Directors, any officer of the Corporation shall give a bond or other security for the faithful performance of his or her duties, in such amount and with such surety as the Board of Directors may require. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 16.</B><B> </B><B>ABSENCE OR DISABILITY OF OFFICERS.</B> In the case of the absence or disability of any officer of the Corporation
and of any person hereby authorized to act in such officer&#146;s place during such officer&#146;s absence or disability, the Board of Directors may by resolution delegate the powers and duties of such officer to any other officer or to any
director, or to any other person selected by it. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CERTIFICATES OF STOCK </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 1.</B><B> </B><B>SHARES WITH OR WITHOUT CERTIFICATES.</B> The Board of Directors may authorize that some or all of the shares of
any or all of the Corporation&#146;s classes or series of stock be evidenced by a certificate or certificates of stock. The Board of Directors may also authorize the issue of some or all of the shares of any or all of the Corporation&#146;s classes
or series of stock without certificates. The rights and obligations of stockholders with the same class and/or series of stock shall be identical whether or not their shares are represented by certificates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.</B><B> </B><B>SHARES WITH CERTIFICATES.</B> If the Board of Directors chooses to issue shares of stock evidenced by a
certificate or certificates, each individual certificate shall include the following on its face: (i)&nbsp;the Corporation&#146;s name, (ii)&nbsp;the fact that the Corporation is organized under the laws of the State of Delaware, (iii)&nbsp;the name
of the person to whom the certificate is issued, (iv)&nbsp;the number of shares represented thereby, (v)&nbsp;the class of shares and the designation of the series, if any, which the certificate represents, and (vi)&nbsp;such other information as
applicable law may require or as may be lawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Corporation is authorized to issue different classes of shares or different series
within a class, the designations, relative rights, preferences and limitations determined for each series (and the authority of the Board of Directors to determine variations for future series) may be summarized on the front or back of each
certificate. Alternatively, each certificate may state on its front or back that the Corporation will furnish the stockholder this information in writing, without charge, upon request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each certificate of stock issued by the Corporation shall be signed (either manually or in facsimile) by the chairperson or vice-chairperson
of the Board of Directors, or the president or a vice-president, and by the treasurer or an assistant treasurer, or the secretary or an assistant secretary of the Corporation. If the person who signed a certificate no longer holds office when the
certificate is issued, the certificate is nonetheless valid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.</B><B> </B><B>SHARES WITHOUT CERTIFICATES.</B> If the Board of
Directors chooses to issue shares of stock without certificates, the Corporation, if required by the General Corporation Law of the State of Delaware, shall, within a reasonable time after the issue or transfer of shares without certificates, send
the stockholder a written statement of the information required on certificates by <U>Section</U><U></U><U>&nbsp;2</U> of <U>Article V</U> of these Bylaws and any other information required by the General Corporation Law of the State of Delaware.
The Corporation may adopt a system of issuance, recordation and transfer of its shares of stock by electronic or other means not involving the issuance of certificates, provided the use of such system by the Corporation is permitted in accordance
with applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.</B><B> </B><B>SUBSCRIPTIONS FOR SHARES.</B> Subscriptions for shares of the Corporation shall be valid
only if they are in writing. Unless the subscription agreement provides otherwise, subscriptions for shares, regardless of the time when they are made, shall be paid in full at such time, or in such installments and at such periods, as shall be
determined by the Board of Directors. All calls for payment on subscriptions shall be uniform as to all shares of the same class or of the same series, unless the subscription agreement specifies otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.</B><B> </B><B>TRANSFERS</B><B>.</B> Transfers of shares of the capital stock
of the Corporation shall be made only on the books of the Corporation by (i)&nbsp;the holder of record thereof, (ii)&nbsp;by his or her legal representative, who, upon request of the Corporation, shall furnish proper evidence of authority to
transfer, or (iii)&nbsp;his or her attorney, authorized by a power of attorney duly executed and filed with the secretary of the Corporation or a duly appointed transfer agent. Such transfers shall be made only upon surrender, if applicable, of the
certificate or certificates for such shares properly endorsed and with all taxes thereon paid. Shares of capital stock of the Corporation that are not represented by a certificate shall be transferred in accordance with applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.</B><B> </B><B>LOST, DESTROYED OR STOLEN CERTIFICATES.</B> In case of loss, mutilation or destruction of a certificate of stock,
a duplicate certificate may be issued upon the terms prescribed by the Board of Directors, including provision for indemnification of the Corporation secured by a bond or other security sufficient to protect the Corporation against any claim that
may be made against it, including any expense or liability, on account of the alleged loss, theft or destruction of the certificate or the issuance of the replacement certificate. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL
PROVISIONS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 1.</B><B> </B><B>DIVIDENDS.</B> Dividends upon the capital stock of the Corporation, subject to the
provisions of the Certificate of Incorporation, if any, may be declared by the Board of Directors at any regular or special meeting, in accordance with applicable law. Dividends may be paid in cash, in property or in shares of the capital stock,
subject to the provisions of applicable law and the Certificate of Incorporation. Before payment of any dividend, there may be set aside out of any funds of the Corporation available for dividends such sum or sums as the directors from time to time,
in their absolute discretion, think proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the Corporation, or any other purpose and the directors may modify or abolish any
such reserve in the manner in which it was created. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.</B><B> </B><B>CHECKS, NOTES, DRAFTS, ETC.</B> All checks, notes, drafts
or other orders for the payment of money of the Corporation shall be signed, endorsed or accepted in the name of the Corporation by such officer, officers, person or persons as from time to time may be designated by the Board of Directors or by an
officer or officers authorized by the Board of Directors to make such designation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.</B><B> </B><B>CONTRACTS.</B> In addition
to the powers otherwise granted to officers pursuant to <U>Article IV</U> hereof, the Board of Directors may authorize any officer or officers, or any agent or agents, of the Corporation to enter into any contract or to execute and deliver any
instrument in the name of and on behalf of the Corporation, and such authority may be general or confined to specific instances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.</B><B> </B><B>LOANS.</B> Subject to compliance with applicable law (including the Sarbanes-Oxley Act of 2002, as amended), the
Corporation may lend money to, or guarantee any obligation of, or otherwise assist any officer or other employee of the Corporation or of its subsidiaries, including any officer or employee who is a director of the Corporation or its subsidiaries,
whenever, in the judgment of the directors, such loan, guaranty or assistance may reasonably be expected to benefit the Corporation. The loan, guaranty or other assistance may be with or without interest, and may be unsecured, or secured in such
manner as the Board of Directors shall approve, including, without limitation, a pledge of shares of stock of the Corporation. Nothing in this <U>Section</U><U></U><U>&nbsp;4</U> shall be deemed to deny, limit or restrict the powers of guaranty or
warranty of the Corporation at common law or under any statute. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.</B><B> </B><B>FISCAL YEAR.</B> The fiscal year of the Corporation shall end on
December&nbsp;31 of each fiscal year and may hereafter be changed by resolution of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.</B><B>
</B><B>CORPORATE SEAL.</B> The seal of the Corporation shall be in such form as shall be approved by the Board of Directors. The seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise.
Notwithstanding the foregoing, no seal shall be required by virtue of this <U>Section</U><U></U><U>&nbsp;6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.</B><B>
</B><B>VOTING SECURITIES OWNED BY CORPORATION.</B> Voting securities in any other entity held by the Corporation shall be voted by the chief executive officer, the president or a vice-president, unless the Board of Directors specifically confers
authority to vote with respect thereto, which authority may be general or confined to specific instances, upon some other person or officer. Any person authorized to vote securities shall have the power to appoint proxies, with general power of
substitution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 8.</B><B> </B><B>INSPECTION OF BOOKS AND RECORDS.</B> The Board of Directors shall have power from time to time
to determine to what extent and at what times and places and under what conditions and regulations the accounts and books of the Corporation, or any of them, shall be open to the inspection of the stockholders; and no stockholder shall have any
right to inspect any account or book or document of the Corporation, except as conferred by the laws of the State of Delaware, unless and until authorized so to do by resolution of the Board of Directors or of the stockholders of the Corporation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 9.</B><B> </B><B>SECTION HEADINGS.</B> Section headings in these Bylaws are for convenience of reference only and shall not be
given any substantive effect in limiting or otherwise construing any provision herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 10.</B><B> </B><B>INCONSISTENT
PROVISIONS.</B> In the event that any provision of these Bylaws is or becomes inconsistent with any provision of the Certificate of Incorporation, the General Corporation Law of the State of Delaware or any other applicable law, the provision of
these Bylaws shall not be given any effect to the extent of such inconsistency but shall otherwise be given full force and effect. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>AMENDMENTS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
furtherance and not in limitation of the powers conferred by statute, the Board of Directors of the Corporation is expressly authorized to make, alter, amend, change, add to or repeal these Bylaws by the affirmative vote of a majority of the total
number of directors then in office. Any amendment, alteration, change, addition or repeal of these Bylaws by the stockholders of the Corporation shall require the affirmative vote of the holders of at least a majority of the outstanding shares of
the Corporation, voting together as a class, entitled to vote on such amendment, alteration, change, addition or repeal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * * * </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hca-20221219.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 12/20/2022 2:40:35 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:hca="http://hcahealthcare.com/20221219"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://hcahealthcare.com/20221219"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hca-20221219_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hca-20221219_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>hca-20221219_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 12/20/2022 2:40:35 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>hca-20221219_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 12/20/2022 2:40:35 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hca-20221219.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140049064839488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 19, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000860730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 19,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HCA HEALTHCARE, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3865930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Park Plaza<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(615)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">344-9551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HCA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d385362d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hca-20221219.xsd" xlink:type="simple"/>
    <context id="duration_2022-12-19_to_2022-12-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000860730</identifier>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2022-12-19_to_2022-12-19">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-12-19_to_2022-12-19"
      id="Hidden_dei_EntityCentralIndexKey">0000860730</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2022-12-19_to_2022-12-19"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2022-12-19_to_2022-12-19">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2022-12-19_to_2022-12-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-12-19_to_2022-12-19">2022-12-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-12-19_to_2022-12-19">HCA HEALTHCARE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-12-19_to_2022-12-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-12-19_to_2022-12-19">001-11239</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-12-19_to_2022-12-19">27-3865930</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-12-19_to_2022-12-19">One Park Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-12-19_to_2022-12-19">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-12-19_to_2022-12-19">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-12-19_to_2022-12-19">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-12-19_to_2022-12-19">(615)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-12-19_to_2022-12-19">344-9551</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-12-19_to_2022-12-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-12-19_to_2022-12-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-12-19_to_2022-12-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-12-19_to_2022-12-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-12-19_to_2022-12-19">Common Stock, $.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-12-19_to_2022-12-19">HCA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-12-19_to_2022-12-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-12-19_to_2022-12-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M0H6354\UUH9G!   (1$  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R-
MF&]OZC84QK^*E4W3)I42A_\=(%%*5W1[N:BP7=U->V$2 U:3.-=VH-VGWW&
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " !"A9-5)!Z;HJT
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M2P$"% ,4    " !"A9-5!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $*%DU6U$^J:[0   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M $*%DU697)PC$ 8  )PG   3              "  <L!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ 0H6354\UUH9G!   (1$  !@
M     ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M $*%DU6?H!OPL0(  .(,   -              "  :D,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ 0H6359>*NQS     $P(   L              ( !
MA0\  %]R96QS+RYR96QS4$L! A0#%     @ 0H6351PX9>H_ 0  / (   \
M             ( !;A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( $*%
MDU4D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $*%DU5ED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d385362d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d385362d8k.htm">d385362d8k.htm</File>
    <File>d385362dex31.htm</File>
    <File>hca-20221219.xsd</File>
    <File>hca-20221219_lab.xml</File>
    <File>hca-20221219_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d385362d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d385362d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hca-20221219_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hca-20221219_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hca-20221219.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hca",
   "nsuri": "http://hcahealthcare.com/20221219",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d385362d8k.htm",
      "contextRef": "duration_2022-12-19_to_2022-12-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d385362d8k.htm",
      "contextRef": "duration_2022-12-19_to_2022-12-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20221219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-22-308372-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-308372-xbrl.zip
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M0VE4D2M1+EI'#Y ?UI@T&"VK:T%=#R;+_GS?O)I6#Y+K3ZOF TD]U16R3P,
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M'&;DHP!LH+)G1)_&#P+&HD::M RACO#1R  L:20UW8MD^LBGO@^;Q&C3!Z'
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M9R590.5X/D!^R"D_S9L_J*+_W,KY_P%02P,$%     @ 0H6359'&[+<D?
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M9:#:8%ENV$:(R1#\@3!$6>B-WH(SX7-O! ].%.@WQE.G2SAYLGJ!KFWR%I<
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MJX2J9C@([\X )D#!4X/- H_.<[N9<Q3T+,1H,LI8W/B&KS[X+N=I9IR7=J5
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M/@H3@DMU<5EP2C_[;\2P'UF^J8<+=:A)T9I*O09<SC.<Z8M[<'=XS(>:L!L
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M/*?&/99KG:]=^U1Z!C^WQ\GR 67GR/NVLG=N'MIC_75QA@BF(/PFW-Y#?L
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MVT#E4"@0CHON)/[>G!9Y/\R1\G-3KC>9.K^_R3#*DF[\NF3%V[RP<T/-U?9
M:WE;$+L:9&FW73B0\^[*H7U@TZT</>6+3C\A^EHU5H+6[A.&^!1CYXEL&1X>
M_,&8,EPVS:)+!4'.4:;7-^Q A@/80 (9NPI?R:<?N]))Y"BK9X4>PDSH/OF
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M/:=9FS+,6-0VB%<@I7ZA65Y.>A%[6+WOQ+H0AZ9I6F#],C456Y(8NZ4Y8*C
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MGWF)4^_Y!U!+ 0(4 Q0    ( $*%DU4*YR5YZ@\  --H   .
M  "  0    !D,S@U,S8R9#AK+FAT;5!+ 0(4 Q0    ( $*%DU61QNRW)'P
M !Z$ @ 0              "  180  !D,S@U,S8R9&5X,S$N:'1M4$L! A0#
M%     @ 0H6353-)6PP^ P  30L  !               ( !:(P  &AC82TR
M,#(R,3(Q.2YX<V102P$"% ,4    " !"A9-53W<1^X\&  "L1@  %
M        @ '4CP  :&-A+3(P,C(Q,C$Y7VQA8BYX;6Q02P$"% ,4    " !"
MA9-5[ A27M$$   ^+   %               @ &5E@  :&-A+3(P,C(Q,C$Y
>7W!R92YX;6Q02P4&      4 !0 \ 0  F)L

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
